http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SI-2935255-T1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_53810094575edc7546de6511f90fa6b0
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-00
filingDate 2013-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59ac51b9161d9a747211da7548d72526
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27375a3db0b0ea2b09e9f839877398f0
publicationDate 2018-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber SI-2935255-T1
titleOfInvention PROCEDURE FOR PREPARATION OF RIVAROKSABAN
abstract The present invention relates to rivaroxaban, more particularly to a process for preparation of rivaroxaban characterized in that the (S) -4- (4- (5- (aminomethyl ) -2-oxooxazolidin-3 yl) phenyl) morpholin-3-one hydrochloride is reacted with 5-chlorothiophene-2-carbonyl chloride in a reaction medium which comprises 1-methylimidazole, to new polymorphic form K and to a process of its crystallization.
priorityDate 2012-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16037077
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1390
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID589223
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538408
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419530971
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8857
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558802
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416026556
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8900
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419475894
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9875401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449789499

Total number of triples: 29.